Institut für Radiologie, Kantonsspital Winterthur, Brauerstrasse 15, 8401 Winterthur
Sabine Sartoretti is a 54 years old neuroradiologist with 25 years experience in diagnostic neuroradiology. She was trained in radiology and neuroradiology at University Hospital of Zürich and at Waidspital in Zürich and has worked as a staff member in neuroradiology at University Hospital of Zürich, at the private hospital Klinik im Park at Zürich and since 2009 as chief of service in neuroradiology at Kantonsspital Winterthur. She has been “Privatdozent” for neuroradiology at University of Zürich since 2001. Her recent research work deals with DIR in multiple sclerosis and with zoom diffusion in pathologies of brainstem and hippocampus.
Kantonsspital Winterthur was chosen as one of the first sites internationally for the application of the compressed sense technique in autumn 2017 and Sabine Sartoretti has experience of 6 months with this new technique used daily with neuroradiological MRI examinations.
Compressed Sense Technique in Neuroradiology
The compressed SENSE (CS) technique aims both at speeding up sequences and / or at improving the image quality by increasing the spatial resolution. CS reduces scan times of 2D/3D scans on 1.5 T / 3T scanners by up to 50%. CS can be applied for all anatomies and with nearly all sequences available. Application of CS with varying CS factors and denoising grades in the field of neuroradiology will be demonstrated.
EVEN MORE SEMINARS
Professor David Maintz University Hospital Cologne, Department of Radiology
Spectral CT: Dual layer technology helps to increase diagnostic confidence
Dr Youssef Mentias City Hospitals Sunderland NHS Foundation Trust
Review of Hypopharyngeal and Laryngeal pathology
Sanjay Prabhu, MBBS Harvard Medical School / Boston Children’s Hospital
Evolving role of machine learning in brain tumour imaging
Laura Allington University College London Hospitals NHS Foundation Trust
Operational challenges of planning a new NHS high energy proton service.
Dr John Buscombe British Nuclear Medicine Society
Theranostics in prostate cancer new or false dawn